Ameriprise’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $323K | Sell |
23,131
-35,140
| -60% | -$491K | ﹤0.01% | 3639 |
|
|
2025
Q1 | $785K | Buy |
58,271
+9,478
| +19% | +$128K | ﹤0.01% | 3275 |
|
|
2024
Q4 | $935K | Buy |
48,793
+6,806
| +16% | +$130K | ﹤0.01% | 3245 |
|
|
2024
Q3 | $955K | Buy |
41,987
+21,002
| +100% | +$478K | ﹤0.01% | 3229 |
|
|
2024
Q2 | $273K | Buy |
+20,985
| New | +$273K | ﹤0.01% | 3612 |
|
|
2023
Q1 | – | Sell |
-267,765
| Closed | -$7.82M | – | 4034 |
|
|
2022
Q4 | $7.82M | Buy |
+267,765
| New | +$7.82M | ﹤0.01% | 1952 |
|